By Alex Wolf ( February 25, 2016, 6:53 PM EST) -- A Johnson & Johnson pharmaceutical unit urged a Pennsylvania appeals court on Wednesday to affirm a litmus test ruling that over 250 men and boys claiming they grew female breasts after taking anti-psychotic drug Risperdal had waited too long to sue, saying they failed to do timely due diligence....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.